ICoLA 2019

Date	Time	Room	Session/Title	Presentation Time	Presentation Title	Role
Sep. 5 (Thu.)	16:00-17:30	Room 5	Symposium 2 / Reappraisal of Immune Cells in Cardiovascular Disease	16:20-16:40	Macrophage Immunometabolism in Heart	Chairperson
Sep. 5 (Thu.)	16:00-17:30	Room 5	Symposium 2 / Reappraisal of Immune Cells in Cardiovascular Disease	16:20-16:40	Macrophage Immunometabolism in Heart	Chairperson

BREAKFAST SYMPOSIUM 1 [AstraZeneca]: Sep.10(Fri.)

Chairperson Jung-hyun Noh (Inje University, Korea)

08:00-08:20	For today for tomorrow, cardiorenal benefit of dapagliflozin Jae Hyuk Lee (Myongji Hospital, Korea)
08:20-08:30	Discussion

BREAKFAST SYMPOSIUM 2 [Pfizer/BMS]: Sep.10(Fri.)

Chairperson Eung Gyu Kim (Inje University, Korea)

08:00-08:20	Can my elderly AF patients benefit in anticoagulation? : broad data of Eliquis can tell Seung Yong Shin (Chung-Ang University, Korea)
08:20-08:30	Discussion

BREAKFAST SYMPOSIUM 3 [Sanofi]: Sep.10(Fri.)

Chairperson Seonghoon Choi (Hallym University, Korea)

08:00-08:20	A novel strategy for the lipid management of recent ACS patients - Praluent Jin Joo Park (Seoul National University, Korea)
08:20-08:30	Discussion

: Sep.10(Fri.); Room 1+2+3

Chairperson Donghoon Choi (Yonsei University, Korea)

What’s new in epidemiology of atherosclerotic cardiovascular disease and its risk factors Raul D. Santos (University of Sao Paulo, Brazil)

BREAK: Sep.10(Fri.)

SYMPOSIUM 1 Emerging risk factors for atherosclerosis: Sep.10(Fri.)

Chairpersons In-Kyu Lee (Kyungpook National University, Korea)
Myung-A Kim (Seoul National University, Korea)

09:40-10:03	NAFLD, NASH & cardiovascular disease Masahiro Koseki (Osaka University, Japan)
10:03-10:26	Leukocytes, inflammation, and atherosclerosis Marit Westerterp (University of Groningen, Netherlands)
10:26-10:49	Heterogeneity of NAFLD from the perspective of atherosclerosis Bo Kyung Koo (Seoul National University, Korea)
10:49-11:15	Discussion

SYMPOSIUM 2 Risk assessment for primary prevention: Sep.10(Fri.)

Chairpersons Sang-Hyun Kim (Seoul National University, Korea)
Cheol-Young Park (Sungkyunkwan University, Korea)

09:40-10:03	Integration of new imaging or biomarkers to risk calculators Chang-Yeon Kim (Daegu Catholic University, Korea)
10:03-10:26	Understanding cardiovascular risk: using risk scores and other risk-based testing in the contemporary era Ian Neeland (University Hospitals Cleveland Medical Center, USA)
10:26-10:49	Risk model for CV risk assessment in Korean population Seung-Hwan Lee (The Catholic University of Korea, Korea)
10:49-11:15	Discussion

SYMPOSIUM 3 Clinical implication of genetic/epigenetic studies on coronary artery disease & dyslipidemia: Sep.10(Fri.)

Chairpersons Kyong Soo Park (Seoul National University, Korea)
Young Joon Hong (Chonnam National University, Korea)

09:40-10:03	Mapping genetic associations to novel therapeutics for cardiometabolic disease Pradeep Natarajan (Harvard Medical School, USA)
10:03-10:26	Clinical implication of recent epigenetic studies on CAD & dyslipidemia Sung Ho Park (UNIST, Korea)
10:26-10:49	How can we derive biological relevance from genetic studies on atherosclerosis? Mete Civelek (University of Virginia, USA)
10:49-11:15	Discussion

SYMPOSIUM 4 Immune cells in blood vessels: Sep.10(Fri.)

Chairpersons Kiyuk Chang (The Catholic University of Korea, Korea)
Young Mi Park (Ewha Womans University, Korea)

09:40-10:03	Myeloid cell heterogeneity in hyperlipidemic cardiovascular diseases Jae Hoon Choi (Hanyang University, Korea)
10:03-10:26	Role of immune cells in the regression of atherosclerosis: conversations between fat and the plaque Edward A. Fisher (NYU Grossman School of Medicine, USA)
10:26-10:49	Role of LYVE-1+ macrophage in arterial diseases Veronique Angeli (National University of Singapore, Singapore)
10:49-11:15	Discussion

SYMPOSIUM 5 New look at smooth muscle cells in atherosclerosis: Sep.10(Fri.)

Chairpersons Jae-Ryong Kim (Yeungnam University, Korea)
Do-Sun Lim (Korea University, Korea)

09:40-10:03	Cellular plasticity in atherosclerosis Judith Sluimer (Maastricht University, Netherlands)
10:03-10:26	Biological Role of APE1/Ref-1 in Vascular Calcification Byeong Hwa Jeon (Chungnam National University, Korea)
10:26-10:49	Phenotypic changes of VSMC in atherosclerosis Chang Seon Myung (Chungnam National University, Korea)
10:49-11:15	Discussion

COFFEE BREAK: Sep.10(Fri.)

OPENING ADDRESS: Sep.10(Fri.)

: Sep.10(Fri.); Room 1+2+3

Chairperson Goo Taeg Oh (Ewha Womans University, Korea)

Single cell RNA and antibody sequencing in women and men with cardiovascular disease Klaus Ley (La Jolla Institute for Immunology, USA)

LUNCHEON SYMPOSIUM 1 [Organon]: Sep.10(Fri.)

Chairperson Hong Kyu Lee (Seoul National University, Korea)

12:05-12:25	Insight for T2DM and/or metabolism syndrome with complication to manage dyslipidemia Seung-Hwan Lee (The Catholic University of Korea, Korea)
12:25-12:35	Discussion

LUNCHEON SYMPOSIUM 2 [Amgen]: Sep.10(Fri.)

Chairperson Hyun Ho Shin (Asan Chungmu Hospital, Korea)

12:05-12:25	Familial hypercholesterolemia: diagnosis and management Chan Joo Lee (Yonsei University, Korea)
12:25-12:35	Discussion

LUNCHEON SYMPOSIUM 3 [Viatris]: Sep.10(Fri.)

Chairperson Donghoon Choi (Yonsei University, Korea)

12:05-12:25	What are the optimal options of dyslipidemia management for your patients? based on treatment continuum Hyun Jae Kang (Seoul National University, Korea)
12:25-12:35	Discussion

LUNCHEON SYMPOSIUM 4 [Yuhan]: Sep.10(Fri.)

Chairperson Shung Chull Chae (Kyungpook National University, Korea)

12:05-12:25	The needs for combination therapy (Ezetimibe and Statin) Hyo-In Choi (Sungkyunkwan University, Korea)
12:25-12:35	Discussion

ORAL PRESENTATION 1: Sep.10(Fri.)

Chairperson Hyuk-Sang Kwon (The Catholic University of Korea, Korea)
Sang Hyun Ihm (The Catholic University of Korea, Korea)

Scientific Excellence Award Lecture: Sep.10(Fri.)

Chairpersons Hak Chul Jang (Seoul National University, Korea)
Donghoon Choi (Yonsei University, Korea)

13:05-13:10	2021 KSoLA Awards ceremony for Scientific Excellence and Young Investigator
13:10-13:30	Roles of myeloid cells in the pathogenesis of atherosclerosis Goo Taeg Oh (Ewha Womans University, Korea)
13:30-13:35	Q&A

ORAL PRESENTATION 2: Sep.10(Fri.)

Chairperson Chul Sik Kim (Yonsei University, Korea)
Jong Chul Won (Inje University, Korea)

: Sep.10(Fri.); Room 1+2+3

Chairperson Hak Chul Jang (Seoul National University, Korea)

Optimal medical therapy to inhibit coronary plaque Ken-ichi Hirata (Kobe University, Japan)

COFFEE BREAK: Sep.10(Fri.)

SYMPOSIUM 6 TG metabolism & lipolysis: Sep.10(Fri.)

Chairpersons Hong-Seog Seo (Korea University, Korea)
Byung Wan Lee (Yonsei University, Korea)

14:45-15:08	Is remnant lipoprotein atherogenic? Ki Hoon Han (University of Ulsan, Korea)
15:08-15:31	New therapeutics based on TG metabolism Hye-Jin Yoo (Korea University, Korea)
15:31-15:54	Targeting ANGPTL3 to reduce LDL cholesterol, triglyceride-rich lipoproteins, and cardiovascular disease Nathan Stitziel (University of Washington, USA)
15:54-16:20	Discussion

SYMPOSIUM 7 Imaging of atherosclerosis: Sep.10(Fri.)

Chairpersons Moon-Kyu Lee (Eulji University, Korea)
Dong-Eog Kim (Dongguk University, Korea)

14:45-15:08	Latest target molecules in imaging early & late atherosclerosis Jin-Won Kim (Korea University, Korea)
15:08-15:31	Molecular imaging in atherosclerosis Jung-joon Min (Chonnam National University, Korea)
15:31-15:54	Update on invasive imaging of vulnerable plaque So-Yeon Choi (Ajou University, Korea)
15:54-16:20	Discussion

SYMPOSIUM 8 Role of endothelial cells & ROS in atherosclerosis: Sep.10(Fri.)

Chairpersons Young-Guen Kwon (Yonsei University, Korea)
Weon Kim (Kyung Hee University, Korea)

14:45-15:08	Disturbed Flow Induces Endothelial Reprograming and Atherosclerosis. Lessons from single-cell RNAseq and ATACseq study Hanjoong Jo (Emory University, USA)
15:08-15:31	Update on endothelial cell as target of anti-atherosclerosis treatment Kyung-Sun Heo (Chungnam National University, Korea)
15:31-15:54	The Roles of peroxiredoxins in the pathogenesis of atherosclerosis Goo Taeg Oh (Ewha Womans University, Korea)
15:54-16:20	Discussion

SYMPOSIUM 9 Korean Dietary Reference Intakes(KDRI) for chronic disease risk reduction: Sep.10(Fri.)

Chairpersons Oran Kwon (Ewha Womans University , Korea)
Myoungsook Lee (Sungshin Women’s University, Korea)

14:45-15:03	Dietary cholesterol recommendation for cardiovascular risk Sung Nim Han (Seoul National University, Korea)
15:03-15:21	Dietary n-6 polyunsaturated fatty acids (n-6 PUFA) on health: a systematic review of clinical studies in 2014-2019 Gwang-woong Go (Hanyang University, Korea)
15:21-15:39	Dietary fiber and dyslipidemia Ji Yeon Kim (Seoul National University of Science and Technology, Korea)
15:39-15:57	Sodium dietary reference intakes based on CV disease Min-Jeong Shin (Korea University, Korea)
15:57-16:20	Discussion

BREAK: Sep.10(Fri.)

SYMPOSIUM 10 Principles & limitation of current lipid-lowering therapy: Sep.10(Fri.)

Chairpersons Myung Ho Jeong (Chonnam National University, Korea)
Woo Je Lee (University of Ulsan, Korea)

16:30-16:53	Update of lipid-lowering therapy guidelines; difference and similarity Hidenori Arai (National Center for Geriatrics and Gerontology, Japan)
16:53-17:16	Is current stratification of very-high risk group appropriate? Jong-Young Lee (Sungkyunkwan University, Korea)
17:16-17:39	Is current LDL-C target achievable? Sung Hee Choi (Seoul National University, Korea)
17:39-18:05	Discussion

SYMPOSIUM 11 (Joint with IAS) Latest trend of lipid modifying strategies: Sep.10(Fri.)

Chairpersons Chee Jeong Kim (Chung-Ang University, Korea)
Kee Ho Song (Konkuk University, Korea)

16:30-16:53	Optimal treatment & LDL-C target for intermediate/low risk population Samia Mora (Brigham and Women's Hospital, USA)
16:53-17:16	Timing & candidate of combination treatment Sin-Gon Kim (Korea University, Korea)
17:16-17:39	Is it worth to adjust lipid-lowering therapy by ethnicity & how? Mariko Harada-Shiba (National Cerebral and Cardiovascular Center Research Institute, Japan)
17:39-18:05	Discussion

SYMPOSIUM 12 Influence of metabolic dysfunction in atherosclerosis: Sep.10(Fri.)

Chairpersons Kyung Mook Choi (Korea University, Korea)
Jin Han (Inje University, Korea)

16:30-16:53	Mechanism of vascular complications in obesity & metabolic syndrome Soo Lim (Seoul National University, Korea)
16:53-17:16	Immunometabolic control in macrophages Ichiro Manabe (Chiba University, Japan)
17:16-17:39	FABP as therapeutic target in ASCVD Masato Furuhashi (Sapporo University, Japan)
17:39-18:05	Discussion

SYMPOSIUM 13 New techniques in basic atherosclerosis research: Sep.10(Fri.)

Chairpersons Ick Mo Chung (Ewha Womans University , Korea)
Chi Dae Kim (Pusan National University, Korea)

16:30-16:53	New insights from mouse models of diabetes-accelerated atherosclerosis Karin Bornfeldt (University of Washington, USA)
16:53-17:16	Fatty liver disease and gut ecosystem: microbiome and metabolome Do Yup Lee (Seoul National University, Korea)
17:16-17:39	Proteomic studies in atherosclerotic cardiovascular disease Kyung-Gon Kim (University of Ulsan, Korea)
17:39-18:05	Discussion

DINNER: Sep.10(Fri.)

Scientific Program